Ozempic® is an injectable used to improve glycemic control in adults with type 2 diabetes mellitus and is available as 2 mg in a 1.5 mL (1.34 mg/mL) pre-filled, disposable pen injector. Chart available on our eNewsline.
Ozempic® is dosed once weekly. The starting dose is 0.25 mg once weekly for 4 weeks, then increasing to 0.5 mg once weekly. If additional blood sugar control is needed after at least 4 weeks at 0.5 mg , the dosage may be increased to 1 mg once weekly. Due to the confusing billing units (mL) and titration schedule, billing can be challenging. Based on how each patient responds to treatment and their goals, there are a few different clinical scenarios that may occur following the initial 4 weeks on 0.25 mg. See our eNewsline for three patient scenarios.
- The NCPDP billing unit is “mL” so the 1-pen box is billed as 1.5 mL and the 2-pen box is billed as 3 mL
- Submitted days’ supply should be in weekly increments based on the calculations
- After first use, the pens can be stored at room temperature for 56 days
- Update: Medicare Part D Mandatory E-Prescribing Requirements for Controlled Substances – Final Rule - January 11, 2023
- DMEPOS Mini-Series #8 – The Six Medicare Auditing Entities and Their Purpose - December 20, 2022
- Be on the Lookout for OptumRx Unannounced Onsite Audits - December 18, 2022